CBA Pharma Overview
- Year Founded
-
1999

- Status
-
Private
- Latest Deal Type
-
Debt - PPP
- Investors
-
1
CBA Pharma General Information
Description
Developer of chemotherapy drugs intended for the effective treatment of cancer. The company therapies reverse multi-drug resistance in cancer cells and become part of a cancer treatment program that is administered before a cancer cell can become drug-resistant, enabling healthcare professionals to provide hope and opportunity for a normal life span with an improved quality of life to people with a life-threatening disease and reduce drug resistance.
Contact Information
Website
www.cbapharma.comCorporate Office
- 670 Perimeter Drive
- Lexington, KY 40517
- United States
Corporate Office
- 670 Perimeter Drive
- Lexington, KY 40517
- United States
CBA Pharma Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Debt - PPP | 16-Apr-2020 | Completed | Generating Revenue | |||
6. Later Stage VC | 29-Jan-2015 | Completed | Generating Revenue | |||
5. Later Stage VC | 05-Jun-2013 | Completed | Generating Revenue | |||
4. Later Stage VC | 25-Mar-2010 | Completed | Generating Revenue | |||
3. Later Stage VC | 16-Jun-2006 | Completed | Generating Revenue | |||
2. Later Stage VC | 09-Sep-2004 | $70K | $95K | Completed | Startup | |
1. Seed Round | 22-Sep-2003 | $25K | $25K | Completed | Startup |
CBA Pharma Comparisons
Industry
Financing
Details
CBA Pharma Competitors (4)
One of CBA Pharma’s 4 competitors is Nanobiotix, a Formerly VC-backed company based in Paris, France.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Nanobiotix | Formerly VC-backed | Paris, France | ||||
CytImmune Sciences | Private Equity-Backed | Rockville, MD | ||||
Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
Ayala Pharmaceuticals | Corporation | Wilmington, DE |
CBA Pharma Patents
CBA Pharma Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-9254323-B2 | Method and products for enhancing cellular uptake of drug and dietary supplements | Active | 15-Mar-2013 | ||
US-20140275157-A1 | Method and products for enhancing cellular uptake of drug and dietary supplements | Active | 15-Mar-2013 | ||
US-9517234-B2 | Tetrandrine family pharmaceutical formulations and method | Active | 15-Mar-2013 | ||
US-10815243-B2 | Tetrandrine family pharmaceutical formulations and method | Active | 15-Mar-2013 | ||
US-20140275137-A1 | Tetrandrine family pharmaceutical formulations and method | Active | 15-Mar-2013 | C07D491/147 |
CBA Pharma Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Symetryx Corporation | Venture Capital | Minority |
CBA Pharma FAQs
-
When was CBA Pharma founded?
CBA Pharma was founded in 1999.
-
Where is CBA Pharma headquartered?
CBA Pharma is headquartered in Lexington, KY.
-
What industry is CBA Pharma in?
CBA Pharma’s primary industry is Drug Discovery.
-
Is CBA Pharma a private or public company?
CBA Pharma is a Private company.
-
What is CBA Pharma’s current revenue?
The current revenue for CBA Pharma is
. -
How much funding has CBA Pharma raised over time?
CBA Pharma has raised $9.5M.
-
Who are CBA Pharma’s investors?
Symetryx Corporation has invested in CBA Pharma.
-
Who are CBA Pharma’s competitors?
Nanobiotix, CytImmune Sciences, Inovio Pharmaceuticals, and Ayala Pharmaceuticals are competitors of CBA Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »